Sign in

NCT04436731CompletedEarly phase 1

Sex Disparities in Hypoxic Sympatholysis and Impact of Obesity

Source: ClinicalTrials.gov · Last updated 28 Jul 2026

Brief summary (registry, in English)

Patients with sleep apnea are at increased risk of developing cardiovascular disease - with women at potentially greater risk than men. Contributing mechanisms are not well understood, but may be related to how women respond to low oxygen and, given over 70% of patients with sleep apnea are obese, the impact of obesity. This project seeks to increase our understanding of mechanisms that may contribute to sex differences in the cardiovascular response to low oxygen with the hope that this knowledge will improve the efficacy of current therapies and support the discovery of novel therapeutics.

Status (registry)
Completed
Phase (registry)
Early phase 1
Study type
Interventional
Enrollment
73 (actual)
First submitted
8 Jun 2020
Start date
9 Dec 2020
Primary completion date
2 Jul 2026
Lead sponsor
University of Missouri-Columbia
Diseases
Obesity
NCT number
NCT04436731

What you commit to

  • Study type: Interventional · Early phase 1
  • Participants enrolled: 73
  • From 9 Dec 2020 to the primary completion date, 2 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prescription medications, Sensitivity to lidocaine

Other illness

  • Increased risk of bleeding, pro-coagulant disorders, clotting disorders, anticoagulation therapy
  • Nerve/neurologic disease
  • Cardiovascular, hepatic, renal, respiratory disease
  • Diabetes, Polycystic ovarian syndrome

Other

  • Pregnancy, breastfeeding, oral hormonal contraceptive use
  • Diagnosed sleep apnea or Oxygen desaturation index \>10 events/hr
  • Current smoking/Nicotine use
  • Blood pressure ≥140/90 mmHg
  • Communication barriers

Who the study is looking for

  • 18-45 years of age (premenopausal)
  • Healthy weight (BMI ≥18 and ≤25 kg/m2)
  • Obese (BMI ≥30 kg/m2)

Age in the registry: 18 years to 45 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Missouri - Columbia
Coordinator of this site? Confirm its status
ColumbiaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.